http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101928346-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-324 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H17-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 |
| filingDate | 2016-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101928346-B1 |
| titleOfInvention | Novel mangiferin derivatives and composition having anti-inflammatory activity comprising the same |
| abstract | TECHNICAL FIELD The present invention relates to a maculopyrine derivative which inhibits nitric oxide production and an anti-inflammatory composition comprising the maculopyrin derivative and an effective ingredient thereof. The present invention has an excellent effect of inhibiting the NO production of macrophages and has no side effects. The macroreticular perine derivative of the present invention is characterized in that it is produced by irradiating a mixed solution obtained by mixing maculopyrine with radiation, wherein the maculiperidine derivative is represented by the following Chemical Formula 1, Chemical Formula 2, Chemical Formula 3 . [Chemical Formula 1] (2) (3) |
| priorityDate | 2016-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 148.